Looking for volunteers
Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
NCT06673602 · Qinhuangdao Hospital of Traditional Chinese Medicine · Updated 6 Nov 2024
- What is being tested
- FCYC+Conventional treatment; conventional treatment
- For
- Cognitive Impairment; Intracerebral Hemorrhage
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years and older. About 200 people. The full rules are on the registry page.
- Where
- China (6 sites)
- When
- Starts or started 4 Nov 2024, ends 30 June 2026. Registered 5 Nov 2024.
- Results
- None posted yet.
In the researchers' words
This is a randomized, controlled clinical study conducted across multiple centers. The neurosurgical robot can be used to treat patients with acute intracerebral hemorrhage (ICH). Establish a cohort comprising 200 participants with cognitive impairment after robot-assisted neurosurgery treatment for ICH. Two hundred participants are randomly assigned to either an experimental group (n=100) or a control group (n=100). The experimental group receive conventional treatment and oral administration of Fufang Congrong Yizhi Capsules (FCYC) for 12 weeks, while the control group receive only conventional treatment. The object of the current study is 1) to observe the security and effectiveness of FCYC and 2) to decipher the contributing factors to cognitive impairment after robot-assisted neurosurgery treatment for intracerebral hemorrhage.
Sites
- Second Affiliated Hospital of Tsinghua UniversityBeijing, Beijing Municipality, China
- Qinhuangdao Hospital of Traditional Chinese MedicineQinhuangdao, Hebei, China
- Kaifeng Third People's HospitalKaifeng, Henan, China
- Shandong Public Health Clinical CenterJinan, Shandong, China
- Weifang Hospital of Traditional Chinese MedicineWeifang, Shandong, China
- Kunming Sanbo Brain HospitalKunming, Yunnan, China